Viewing Study NCT03303495


Ignite Creation Date: 2025-12-24 @ 1:16 PM
Ignite Modification Date: 2026-01-03 @ 9:31 PM
Study NCT ID: NCT03303495
Status: UNKNOWN
Last Update Posted: 2017-10-06
First Post: 2017-09-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of 2nd-line FOLFIRI ± Bevacizumab vs. Irinotecan ± Bevacizumab in mCRC
Sponsor: Sun Yat-sen University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module